Pre-EclampsiaNCT06180811
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
A study testing Women's Health Delaware Food Farmacy in people with Pre-Eclampsia and Obesity, run by Christiana Care Health Services at 1 site in United States.
Trial summary
The purpose of this study is to conduct a pilot randomized controlled trial of a food is medicine community health worker intervention called the Women's Health Delaware Food Farmacy compared to the usual standard of care among pregnant ChristianaCare patients at risk for adverse clinical outcomes. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Pre-Eclampsia, Obesity, Gestational Diabetes
- What is being tested?
- Women's Health Delaware Food Farmacy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 250 participants
- Where
- 1 siteUnited States
- Study dates
- 2 Jan 2024to Nov 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- ChristianaCare Women's Health patient
- 18 years or older
- 4 to 14 weeks pregnant
- Singleton pregnancy
- Medicaid
- BMI of 30 or higher
- Reside in New Castle County
Who cannot join
- Current diagnosis of type 1 or type 2 diabetes
- Multiple pregnancy
- Currently enrolled in another Community Health Worker program
- Not able to store and prepare meals
- Diagnosed with severe medical comorbidities that might interfere with their ability to participate in the intervention, such as severe psychiatric illness or imminent hospitalization
- Not able to understand and communicate effectively in English or Spanish
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
ChristianaCare Christiana Hospital
Newark, Delaware, 19718
About this study
Official title: Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women: Addressing Social Needs and Improving Health Outcomes
The purpose of this study is to conduct a pilot randomized controlled trial of a food is medicine community health worker intervention called the Women's Health Delaware Food Farmacy compared to the usual standard of care among pregnant ChristianaCare patients at risk for adverse clinical outcomes. The pilot study has three specific aims:
Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed
Read more
Aim 2: To determine the prevalence of and change in social needs
Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care
Read the detailed description
This study is a pilot randomized controlled trial where eligible pregnant ChristianaCare patients will be identified weekly through an automated list, and patients who consent will be randomized to 1 of 2 arms (Women's Health Delaware Food Farmacy vs. usual standard of care). Participants randomized to the Women's Health Delaware Food Farmacy program arm will receive medically tailored groceries that are high in micronutrients critical for a healthy pregnancy. The food provided will be the equivalent of 10 meals per person in the household per week and will be delivered to participants weekly from enrollment to 4 weeks after giving birth. Participants will receive culinary equipment and training, recipes, and educational nutrition videos and will interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. Participants randomized to the usual standard of care arm will continue to receive their standard of care management.
All participants will complete a questionnaire with patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) at baseline and postpartum and a patient experience survey postpartum related to their experiences receiving prenatal care and giving birth at ChristianaCare. In addition, maternal and child health, healthcare utilization, and clinical event outcomes will be documented for all participants via electronic health records and assessed retrospectively. Quantitative indicators related to feasibility (i.e., acceptability, demand, and implementation) will be collected such as program satisfaction, program enrollment and retention, meals provided to participants and their household, food consumption, and interactions with assigned Community Health Worker.
Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed
H1. Primary outcomes. The investigators hypothesize that the Women's Health Delaware Food Farmacy will: (a) prove acceptable to participants, as measured by program satisfaction; (b) meet demand, as measured by project recruitment and retention, number of meals provided to participants and their household, and number of people providing food for; and (c) prove implementable, as measured by food consumption, number of Community Health Worker interactions, number of educational videos watched, number of recipes reviewed, and number of meal preparation sessions.
Aim 2: To determine the prevalence of and change in social needs
H2. Primary outcome. Social needs will be identified by administering the ChristianaCare Social Determinants of Health Screener and resource referrals will be sent on participants' behalf to support their social needs, both of which are the usual standard of care. The investigators hypothesize that social needs will be identified through the ChristianaCare Social Determinants of Health Screener, and that compared to baseline, participants at postpartum will experience reductions in their social needs. The investigators also hypothesize there will be some participants whose social needs will not be resolved due to a lack of community resources.
Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care
H3a. Primary outcomes. Maternal and child health outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in maternal and child health outcomes (e.g., preeclampsia and small for gestational age) from baseline to postpartum.
H3b. Primary outcomes. Maternal and child healthcare utilization outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child healthcare utilization outcomes (e.g., neonatal intensive care unit [NICU] admission and maternal length of stay) from baseline to postpartum.
H3c. Primary outcomes. Maternal and child clinical event outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child clinical event outcomes (e.g., cesarean delivery and fetal death) from baseline to postpartum.
H3d. Secondary outcomes. Patient-reported outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) from baseline to postpartum.
- Conditions
- Pre-Eclampsia, Obesity, Gestational Diabetes, Gestational Hypertension
- Being tested
- Women's Health Delaware Food Farmacy, Usual Standard of Care
- Keywords
- Food is Medicine, Community Health Worker, Social Needs, Medically Tailored Groceries, Randomized Controlled Trial, Maternal and Child Health
- Medical subject headings
- Pre-Eclampsia, Obesity, Diabetes, Gestational, Hypertension, Pregnancy-Induced
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Women's Health Delaware Food FarmacyOther
Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.
Usual Standard of CareOther
Participants will receive the usual standard of care.
| Study group | Role | What they receive |
|---|---|---|
| Women's Health Delaware Food Farmacy | Experimental | Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. Receives: Other: Women's Health Delaware Food Farmacy |
| Usual Standard of Care | Active comparator | Participants will receive the usual standard of care. Receives: Other: Usual Standard of Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Social Determinants of Health
Measured with ChristianaCare Social Determinants of Health Screener; Number of socials needs range from 0-11, higher scores indicate greater number of social needs
Measured: Changes from baseline to 2-6 weeks after delivery
Gestational Weight Gain
Observed gestational weight gained
Measured: Changes from baseline to 2-6 weeks after delivery
Body Mass Index
Observed body mass index changes
Measured: Changes from baseline to 2-6 weeks after delivery
Gestational Diabetes
Occurrence of gestational diabetes
Measured: From baseline to delivery
Gestational Hypertension
Occurrence of gestational hypertension
Measured: From baseline to delivery
Systolic and Diastolic Blood Pressure
Observed systolic and diastolic blood pressure
Measured: Changes from baseline to 2-6 weeks after delivery
Preeclampsia
Occurrence of preeclampsia and week diagnosed during pregnancy
Measured: From baseline to 2-6 weeks after delivery
Hydramnios
Occurrence of hydramnios
Measured: From baseline to delivery
Gestational Age
Baby's gestational age at birth
Measured: At delivery
Small for Gestational Age
Birth weight less than 10th percentile based on gestational age
Measured: At delivery
Preterm Birth
Preterm birth less than 37 weeks
Measured: At delivery
Fetal Macrosomia
Birth weight greater than 90th percentile based on gestational age
Measured: At delivery
Cesarean Delivery
Occurrence of cesarean delivery including those planned and unplanned
Measured: At delivery
Fetal Death
Occurrence of fetal death
Measured: From baseline to delivery
NICU Admission
Occurrence of NICU admission for any reason
Measured: Within 48 hours after delivery
NICU Length of Stay
Number of days baby was admitted to NICU
Measured: From NICU admission date to NICU discharge date, assessed up to 90 days
Maternal Length of Stay
Number of days hospitalized following delivery
Measured: From delivery date to hospital discharge date, assessed up to 90 days
Postpartum Admission
Number of postpartum hospital admissions for any reason
Measured: From delivery discharge to 90 days after
Postpartum Admission Length of Stay
Number of days hospitalized
Measured: From postpartum admission date to hospital discharge date, assessed up to 90 days
Hospital Admission
Number of hospital admissions for any reason
Measured: From baseline up to delivery
Hospital Admission Length of Stay
Number of days hospitalized
Measured: From admission date to hospital discharge date, assessed up to 90 days
Emergency Room Visit
Number of emergency room visits for any reason
Measured: From baseline to 90 days after delivery
Secondary outcomes (4)
Food Insecurity
Measured with United States Department of Agriculture Household Food Security Survey Module 6-Item Short Form, 30-day; Scores range from 0-6, higher scores indicate lower food security
Measured: Changes from baseline to 2-6 weeks after delivery
Dietary Intake
Measured with Dietary Screener Questionnaire (DSQ-10) and six items from Dietary Screener Questionnaire (DSQ-26); Scores will be calculated using the National Cancer Institute's scoring algorithms
Measured: Changes from baseline to 2-6 weeks after delivery
Health-Related Quality of Life
Measured with Centers for Disease Control and Prevention's Health-Related Quality of Life (HRQOL-4) scale; Number of healthy days range from 0-30, higher scores indicate greater number of healthy days
Measured: Changes from baseline to 2-6 weeks after delivery
Cost-Related Medication Underuse
Measured with Cost-Related Medication Underuse; Scores range from 0-4, scores greater than 0 indicate cost-related medication underuse
Measured: Changes from baseline to 2-6 weeks after delivery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Dec 2023
- Study start2 Jan 2024
- Primary completionNov 2025 (estimated)
- Study completionNov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pre-EclampsiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 250 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Christiana Care Health Services
- Sponsor type
- University, hospital or other
- Collaborators
- University of Delaware
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06180811
- Sponsor's protocol ID
- 605512
- Other IDs
- 90XP0484
- Status last verified
- May 2024
- First submitted
- 6 Dec 2023
- Last updated
- 6 May 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women: Addressing Social Needs and Improving Health Outcomes
- ClinicalTrials.gov ID
- NCT06180811
- Acronym / sponsor ID
- 605512
- Conditions
- Pre-Eclampsia, Obesity, Gestational Diabetes, Gestational Hypertension
- Keywords
- Food is Medicine, Community Health Worker, Social Needs, Medically Tailored Groceries, Randomized Controlled Trial, Maternal and Child Health
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 250 participants (estimated)
- Lead sponsor
- Christiana Care Health ServicesUniversity, hospital or other
- Collaborators
- University of Delaware
- Study start
- 2 Jan 2024 (actual)
- Primary completion
- Nov 2025 (estimated)
- Study completion
- Nov 2025 (estimated)
- First posted
- 26 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to conduct a pilot randomized controlled trial of a food is medicine community health worker intervention called the Women's Health Delaware Food Farmacy compared to the usual standard of care among pregnant ChristianaCare patients at risk for adverse clinical outcomes. The pilot study has three specific aims:
Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed
Aim 2: To determine the prevalence of and change in social needs
Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care
Detailed description
This study is a pilot randomized controlled trial where eligible pregnant ChristianaCare patients will be identified weekly through an automated list, and patients who consent will be randomized to 1 of 2 arms (Women's Health Delaware Food Farmacy vs. usual standard of care). Participants randomized to the Women's Health Delaware Food Farmacy program arm will receive medically tailored groceries that are high in micronutrients critical for a healthy pregnancy. The food provided will be the equivalent of 10 meals per person in the household per week and will be delivered to participants weekly from enrollment to 4 weeks after giving birth. Participants will receive culinary equipment and training, recipes, and educational nutrition videos and will interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. Participants randomized to the usual standard of care arm will continue to receive their standard of care management.
All participants will complete a questionnaire with patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) at baseline and postpartum and a patient experience survey postpartum related to their experiences receiving prenatal care and giving birth at ChristianaCare. In addition, maternal and child health, healthcare utilization, and clinical event outcomes will be documented for all participants via electronic health records and assessed retrospectively. Quantitative indicators related to feasibility (i.e., acceptability, demand, and implementation) will be collected such as program satisfaction, program enrollment and retention, meals provided to participants and their household, food consumption, and interactions with assigned Community Health Worker.
Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed
H1. Primary outcomes. The investigators hypothesize that the Women's Health Delaware Food Farmacy will: (a) prove acceptable to participants, as measured by program satisfaction; (b) meet demand, as measured by project recruitment and retention, number of meals provided to participants and their household, and number of people providing food for; and (c) prove implementable, as measured by food consumption, number of Community Health Worker interactions, number of educational videos watched, number of recipes reviewed, and number of meal preparation sessions.
Aim 2: To determine the prevalence of and change in social needs
H2. Primary outcome. Social needs will be identified by administering the ChristianaCare Social Determinants of Health Screener and resource referrals will be sent on participants' behalf to support their social needs, both of which are the usual standard of care. The investigators hypothesize that social needs will be identified through the ChristianaCare Social Determinants of Health Screener, and that compared to baseline, participants at postpartum will experience reductions in their social needs. The investigators also hypothesize there will be some participants whose social needs will not be resolved due to a lack of community resources.
Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care
H3a. Primary outcomes. Maternal and child health outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in maternal and child health outcomes (e.g., preeclampsia and small for gestational age) from baseline to postpartum.
H3b. Primary outcomes. Maternal and child healthcare utilization outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child healthcare utilization outcomes (e.g., neonatal intensive care unit [NICU] admission and maternal length of stay) from baseline to postpartum.
H3c. Primary outcomes. Maternal and child clinical event outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child clinical event outcomes (e.g., cesarean delivery and fetal death) from baseline to postpartum.
H3d. Secondary outcomes. Patient-reported outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) from baseline to postpartum.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Women's Health Delaware Food Farmacy | Experimental | Other: Women's Health Delaware Food FarmacyParticipants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. |
| Usual Standard of Care | Active comparator | Other: Usual Standard of CareParticipants will receive the usual standard of care. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- ChristianaCare Women's Health patient
- 18 years or older
- 4 to 14 weeks pregnant
- Singleton pregnancy
- Medicaid
Key exclusion criteria (6 listed)
- Current diagnosis of type 1 or type 2 diabetes
- Multiple pregnancy
- Currently enrolled in another Community Health Worker program
- Not able to store and prepare meals
- Diagnosed with severe medical comorbidities that might interfere with their ability to participate in the intervention, such as severe psychiatric illness or imminent hospitalization
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Women's Health Delaware Food FarmacyParticipants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. | Other | Women's Health Delaware Food Farmacy |
| Usual Standard of CareParticipants will receive the usual standard of care. | Other | Usual Standard of Care |
Primary outcome
Social Determinants of Health
Time frame: Changes from baseline to 2-6 weeks after delivery
Measured with ChristianaCare Social Determinants of Health Screener; Number of socials needs range from 0-11, higher scores indicate greater number of social needs
Gestational Weight Gain
Time frame: Changes from baseline to 2-6 weeks after delivery
Observed gestational weight gained
Body Mass Index
Time frame: Changes from baseline to 2-6 weeks after delivery
Observed body mass index changes
Gestational Diabetes
Time frame: From baseline to delivery
Occurrence of gestational diabetes
Gestational Hypertension
Time frame: From baseline to delivery
Occurrence of gestational hypertension
Systolic and Diastolic Blood Pressure
Time frame: Changes from baseline to 2-6 weeks after delivery
Observed systolic and diastolic blood pressure
Preeclampsia
Time frame: From baseline to 2-6 weeks after delivery
Occurrence of preeclampsia and week diagnosed during pregnancy
Hydramnios
Time frame: From baseline to delivery
Occurrence of hydramnios
Gestational Age
Time frame: At delivery
Baby's gestational age at birth
Small for Gestational Age
Time frame: At delivery
Birth weight less than 10th percentile based on gestational age
Preterm Birth
Time frame: At delivery
Preterm birth less than 37 weeks
Fetal Macrosomia
Time frame: At delivery
Birth weight greater than 90th percentile based on gestational age
Cesarean Delivery
Time frame: At delivery
Occurrence of cesarean delivery including those planned and unplanned
Fetal Death
Time frame: From baseline to delivery
Occurrence of fetal death
NICU Admission
Time frame: Within 48 hours after delivery
Occurrence of NICU admission for any reason
NICU Length of Stay
Time frame: From NICU admission date to NICU discharge date, assessed up to 90 days
Number of days baby was admitted to NICU
Maternal Length of Stay
Time frame: From delivery date to hospital discharge date, assessed up to 90 days
Number of days hospitalized following delivery
Postpartum Admission
Time frame: From delivery discharge to 90 days after
Number of postpartum hospital admissions for any reason
Postpartum Admission Length of Stay
Time frame: From postpartum admission date to hospital discharge date, assessed up to 90 days
Number of days hospitalized
Hospital Admission
Time frame: From baseline up to delivery
Number of hospital admissions for any reason
Hospital Admission Length of Stay
Time frame: From admission date to hospital discharge date, assessed up to 90 days
Number of days hospitalized
Emergency Room Visit
Time frame: From baseline to 90 days after delivery
Number of emergency room visits for any reason
4 secondary outcomes
Food Insecurity
Time frame: Changes from baseline to 2-6 weeks after delivery
Dietary Intake
Time frame: Changes from baseline to 2-6 weeks after delivery
Health-Related Quality of Life
Time frame: Changes from baseline to 2-6 weeks after delivery
Cost-Related Medication Underuse
Time frame: Changes from baseline to 2-6 weeks after delivery
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2024.
- Individual participant dataSharing planned: No
Related trials for Pre-Eclampsia
Recruiting
Exercise to Improve Heart and Metabolic Health After Childbirth in Women at High Risk for Preeclampsia
Postpartum Exercise, Cardiometabolic Health
RecruitingObservational study
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
Preeclampsia
Active, not recruitingObservational study
The CoPenHagen PREeClampsia and cardIOvascUlar diSease Study
Pre-Eclampsia, Atherosclerosis
RecruitingObservational study
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Type 1 Diabetes, Preeclampsia
Not yet recruitingPhase 2
Furosemide vs Placebo in Severe Preeclampsia Postpartum
Severe Preeclampsia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Women's Health Delaware Food Farmacy in people with Pre-Eclampsia and Obesity, run by Christiana Care Health Services at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Kathleen McCallops, PhD (3024286590, kathleen.mccallops@christianacare.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Social Determinants of Health (time frame: Changes from baseline to 2-6 weeks after delivery). The study lists 22 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2024.